Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,753.00
Bid: 1,753.00
Ask: 1,753.50
Change: -3.00 (-0.17%)
Spread: 0.50 (0.029%)
Open: 1,743.50
High: 1,755.50
Low: 1,740.50
Prev. Close: 1,756.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Traders bide their time ahead of US jobs data

Mon, 28th Jul 2014 17:26

- BskyB paces gains- Lloyds fined $370m by UK and US authorities- Aberdeen Asset Management sees slight drop in AuMtechMARK 2,776.05 -0.83%FTSE 100 6,788.07 -0.05%FTSE 250 15,616.53 -0.48%The Footsie finished the session slightly lower as traders bided their time ahead of a raft of key data and events later in the week, including the latest US jobs report and a Federal Reserve policy meeting, on Wednesday. Acting as a backdrop, traders continued to closely monitor the worsening security situation in the Gaza strip and Ukraine.That came as US President Barack Obama was scheduled to speak on Monday with several European leaders concerning the crisis in the latter country, with markets eyeing the possibility of further European sanctions against the Russian Federation. The top flight index ended the day 3.48 points below Friday's close of 6,791.55. Financials led on the downside, with Aberdeen Asset Management heading up the fallers. In parallel, RBS gave back some of last Friday's sharp gains after it released its better than expected results ahead of schedule. Of note, Lloyds' share price was hit by news that it had agreed to pay $370m in fines to US and UK authorities.Pending home sales Stateside dropped 1.1% from a month earlier after rising 6% in May, according to the National Association of Realtors. Analysts had forecast a rise of 0.5%.BskyB tops leaderboard Back in the UK, British Sky Broadcasting topped the leaderboard. On Friday the company announced a deal to acquire 21st Century Fox's holdings in Sky Italia and Sky Deutschland. Reckitt Benkiser said that it expects market conditions to remain challenging in the second half of the year, particularly in the US and certain emerging markets, but that it was still on track to achieve its full year total revenue growth target of 4-5%. The household goods group also announced that it is planning to hive off its drug arm into a separate UK-listed company. Aberdeen Asset Management reported a pick-up in business in Asia and emerging markets, but revealed a slight fall in assets under management. Assets under management at June 30th totalled £322.5bn, down 0.6% on the £324.5m at the end of March 2014. Analysts at Credit Suisse upped their price target on shares of RBS to 310p from 280p previously, but retained their 'underperform' rating. The lender is progressing better than expected on the run-down of the assets of its non-core RBS Capital Resolution (RCR) arm, but its valuation already captures the "steady state" profile of returns which can be expected, according to the broker. A breakup of GlaxoSmithKline is a possibility as a result of a sweeping overhaul of the group, according to the Chief Executive of the pharmaceuticals giant, the Financial Times said. Budget airline Ryanair more than doubled its first quarter profit and said it was raising annual profit expectations, but warned of second-half pressure on fares from rival price-cutting. Ryanair said first quarter net profit rose 152% to €197m versus the same time a year ago due partly to a strong Easter, but cautioned that it compared with no holiday in the same period last time.Randgold Resources said it was focusing on its Tongon gold mine in Côte d'Ivoire where it is "continuing to make headway" in its efforts to overcome the technical issues that have affected its performance. Chief Executive Mark Bristow admitted this year's planned ramp-up in production had not been achieved due to the need to expand the flotation circuit and the mechanical failure of the recently installed Vibrocone crushers, intended to improve the recovery and throughput rate. National Grid reported a continued "solid operational and financial performance" between April 1st and July 27th, with the UK delivering operational efficiencies and progress with its investment programme, while the US saw a good operational performance.FTSE 100 - RisersBritish Sky Broadcasting Group (BSY) 904.50p +3.43%Reckitt Benckiser Group (RB.) 5,205.00p +2.66%Fresnillo (FRES) 940.00p +2.12%Pearson (PSON) 1,153.00p +1.86%HSBC Holdings (HSBA) 630.90p +1.48%Aggreko (AGK) 1,757.00p +1.15%BG Group (BG.) 1,212.00p +1.08%Randgold Resources Ltd. (RRS) 5,170.00p +1.08%Centrica (CNA) 315.20p +0.93%National Grid (NG.) 879.00p +0.92%FTSE 100 - FallersAberdeen Asset Management (ADN) 435.00p -5.31%Royal Bank of Scotland Group (RBS) 352.00p -3.35%Kingfisher (KGF) 295.80p -2.89%Royal Mail (RMG) 430.00p -2.52%Smith & Nephew (SN.) 1,033.00p -2.27%Hargreaves Lansdown (HL.) 1,047.00p -1.97%ARM Holdings (ARM) 846.00p -1.86%Meggitt (MGGT) 517.50p -1.62%Glencore (GLEN) 371.95p -1.47%IMI (IMI) 1,412.00p -1.40%FTSE 250 - RisersOphir Energy (OPHR) 207.10p +4.23%Debenhams (DEB) 66.20p +3.28%Infinis Energy (INFI) 239.10p +2.97%Drax Group (DRX) 686.50p +2.69%Petra Diamonds Ltd.(DI) (PDL) 216.60p +2.65%Exova Group (EXO) 240.00p +2.13%Restaurant Group (RTN) 610.00p +2.09%Rightmove (RMV) 2,208.00p +1.75%BH Global Ltd. USD Shares (BHGU) 11.99 +1.61%Fidelity China Special Situations (FCSS) 110.90p +1.37%FTSE 250 - FallersPets at Home Group (PETS) 170.10p -7.05%AO World (AO.) 200.00p -5.70%Xaar (XAR) 543.00p -4.65%CSR (CSR) 555.00p -4.47%Pace (PIC) 355.00p -3.64%JD Sports Fashion (JD.) 386.00p -3.45%Fidessa Group (FDSA) 2,055.00p -3.38%Howden Joinery Group (HWDN) 336.40p -3.19%Evraz (EVR) 95.00p -3.16%Ted Baker (TED) 1,685.00p -3.16%FTSE TechMARK - RisersOxford Biomedica (OXB) 2.92p +2.63%Sarossa (SARS) 1.93p +1.32%Gresham Computing (GHT) 127.00p +0.79%BATM Advanced Communications Ltd. (BVC) 17.00p +0.74%CML Microsystems (CML) 365.00p +0.69%XP Power Ltd. (DI) (XPP) 1,500.00p +0.67%RM (RM.) 165.00p +0.61%Kofax Limited (DI) (KFX) 420.00p +0.36%Skyepharma (SKP) 246.00p +0.10%IShares Euro Gov Bond 7-10YR UCITS ETF (IEGM) € 193.06 +0.09%FTSE TechMARK - FallersElectronic Data Processing (EDP) 72.50p -2.68%Torotrak (TRK) 18.75p -1.96%Vectura Group (VEC) 140.00p -1.93%Dialight (DIA) 939.50p -1.88%Optos (OPTS) 186.00p -1.85%E2V Technologies (E2V) 154.00p -1.75%Promethean World (PRW) 31.00p -1.59%Puricore (PURI) 35.50p -1.39%Anite (AIE) 90.25p -1.37%KCOM Group (KCOM) 93.50p -1.32%AB
More News
21 May 2024 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030

*

Read more
21 May 2024 08:49

GSK's depemokimab asthma treatment meets endpoints in latest trials

(Alliance News) - GSK PLC on Tuesday announced positive results from trials of depemokimab, an "ultra-long-acting biologic" that could simplify treatment options for patients with severe asthma.

Read more
21 May 2024 07:21

GSK reports promising results from asthma treatment trials

(Sharecast News) - GSK announced promising results from phase three clinical trials evaluating the efficacy and safety of depemokimab in treating severe asthma with type 2 inflammation on Tuesday.

Read more
20 May 2024 16:11

IN BRIEF: GSK executive buys GBP20,026 worth shares

GSK PLC - London-based pharmaceuticals firm - Senior Vice President, Global Communications & Chief Executive Office, Sally Jackson, buys 1,120 shares at 1,788 pence each. Worth total GBP20,026.

Read more
17 May 2024 17:38

London's FTSE nudges lower for week after record run

Haleon falls after GSK offloads remaining stake

*

Read more
17 May 2024 15:52

London close: Stocks recoup some earlier losses

(Sharecast News) - London stocks remained in negative territory by Friday's close, although they managed to recoup some of the losses seen earlier in the session as Wall Street opened with positive momentum.

Read more
17 May 2024 11:52

LONDON MARKET MIDDAY: FTSE 100 slides; Eurozone inflation steady

(Alliance News) - Stock prices in London were lacklustre at midday on Friday, as investors eye the trajectory of interest rates across the globe.

Read more
17 May 2024 09:03

TOP NEWS: GSK sells remaining Haleon stake for GBP1.25 billion

(Alliance News) - GSK PLC on Friday said it has sold its remaining shares in Haleon PLC, marking a total exit from its consumer healthcare spin-off.

Read more
17 May 2024 08:56

LONDON MARKET OPEN: FTSE 100 lacklustre as Wall Street rally ends

(Alliance News) - Stock prices in London opened lower on Friday, after Thursday saw Wall Street's rally end in a record breaking session.

Read more
17 May 2024 08:39

GSK raises $1.5 bln from sale of remaining Haleon stake

May 17 (Reuters) - British drugmaker GSK has raised 1.25 billion pounds ($1.52 billion) from a sale of its remaining stake in consumer healthcare company Haleon to institutional investors.

Read more
17 May 2024 07:42

LONDON BRIEFING: Land Securities ups dividend; GSK sells Haleon stake

(Alliance News) - Stocks in London are called to open lower, as investors wait for an inflation reading from the eurozone later this morning.

Read more
17 May 2024 07:29

GSK raises £1.25bn from sale of remaining Haleon stake

(Sharecast News) - GSK said on Friday that it has sold its remaining 4.2% stake in consumer health business Haleon, which it spun off in July 2022.

Read more
16 May 2024 17:33

FTSE 100 ends lower on disappointing corporate updates, BT Group soars

BT Group up after CEO aims for more than double free cash flow

*

Read more
16 May 2024 17:13

TOP NEWS: GSK to sell remaining holding in spin-off Haleon

(Alliance News) - GSK PLC on Thursday said it intends to sell its remaining stake in Haleon PLC, the consumer healthcare firm it spun out almost two years ago.

Read more
16 May 2024 17:02

GSK to sell entire 4.2% remaining stake in Haleon

(Sharecast News) - GSK said on Thursday that it plans to sell its entire remaining 4.2% stake in Haleon.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.